Multiple Myeloma

Small molecule shows promise as anti-cancer therapy

Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division ...

Jan 13, 2014
popularity 5 / 5 (3) | comments 0 | with audio podcast

East Asian genes may solve the skin cancer puzzle

Europeans fall prey to skin cancer because of their lighter skin, while Africans' dark skin protects them. But East Asians, whose skin colour resembles that of Europeans, are similar to Africans in their ...

Jan 07, 2014
popularity 5 / 5 (2) | comments 0

Promising results for Swedish cancer drug candidate

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School and Karolinska Institutet in Sweden presents very promising results for the treatment of the cancer form multiple myeloma. ...

Dec 06, 2013
popularity 5 / 5 (2) | comments 0 | with audio podcast

Latest Spotlight News

At last, hope for ALS patients?

U of T researchers have found a missing link that helps to explain how ALS, one of the world's most feared diseases, paralyses and ultimately kills its victims. The breakthrough is helping them trace a path to a treatment ...

Stem cells from nerves form teeth

Researchers at Karolinska Institutet in Sweden have discovered that stem cells inside the soft tissues of the tooth come from an unexpected source, namely nerves. These findings are now being published in the journal Nature and co ...

$1,000 pill now hepatitis C treatment of choice

(AP)—A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.